WILLS EYE IS HIRING – CLICK HERE TO APPLY TODAY!

Slide 1

AGE-RELATED MACULAR DEGENERATION (AMD)

Wills Eye retina doctors are leading experts in the treatment of macular degeneration with the latest clinical trials and new therapeutic approaches for AMD.

On this page:
AMD-treatment
AMD Treatments
DRY AMD

There is no treatment available yet that can either halt the progression or recover vision loss from dry AMD. Based on epidemiologic studies, certain lifestyle and nutritional changes may be beneficial.

WET AMD

In the past, laser-based therapies were used to target the abnormal blood vessels that cause wet AMD. However, the laser burns typically resulted in scarring and damage to central vision. Fortunately, there are now anti-vascular endothelial growth factor (anti-VEGF) medications available for the treatment of wet AMD. These medications, injected into the eye as an office-based procedure, are currently the preferred therapy for wet AMD due to their unprecedented efficacy. They represent the first therapy that has ever been clinically proven to help improve vision in a substantial proportion of patients with wet AMD. Timing is important, as earlier identification and treatment of wet AMD is associated with better visual outcomes.